Home › Obesity › Arizona › Tucson
Obesity clinical trials in Tucson, AZ
17 studies for Obesity are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RecruitingPhase 3
- University of Arizona, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Tucson Clinical Research Institute, Tucson
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RecruitingPhase 3
- Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, Tucson
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RecruitingPhase 3
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- Pima Heart and Vascular Clinical Research, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 3
- AURORA-1 Clinical Site, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Arizona Clinical Trials, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- Arizona Clinical Trials, Tucson
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Tucson
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RecruitingPhase 2
- Pima Heart, Tucson
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RecruitingPhase 3
- ACCOMPLISH-1 Research Site, Tucson
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
RecruitingPhase 1/2
- Adobe Clinical Research, Tucson
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX44 studies
- Chicago, IL42 studies
- New York City, NY40 studies
- San Antonio, TX39 studies
- Washington, DC33 studies
- Dallas, TX31 studies
- Orlando, FL29 studies
- Boston, MA28 studies
- Miami, FL27 studies
- Las Vegas, NV27 studies
- Atlanta, GA25 studies
- Jacksonville, FL25 studies
Other studies in Tucson
- Breast Cancer20 studies
- Non-Small Cell Lung Cancer17 studies
- Overweight15 studies
- Metastatic Cancer14 studies
- Cancer (all types)13 studies
- Cardiovascular Disease12 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Steatotic Liver Disease10 studies
- Type 2 Diabetes10 studies
- High Blood Pressure10 studies
- Heart Failure10 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.